| Not Yet Recruiting | Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions Post-operative Pain, Bioequivalence Study in Healthy Subjects | Phase 4 | 2024-10-01 |
| Unknown | Evaluate Bioequivalence of Burotam (1/1 g/Vial) Infectious Diseases | Phase 4 | 2022-08-25 |
| Completed | Evaluate Bioequivalence of Micafungin (50mg/Vial) Invasive Candidiasis | Phase 4 | 2022-01-06 |
| Completed | Evaluate Bioequivalence of Palonosetron (0.25mg/5mL) Chemotherapy-induced Nausea and Vomiting, Prophylaxis | Phase 4 | 2020-08-17 |
| Completed | Evaluate Bioequivalence of Voriconazole(200mg/Vial) . Antimycotic for Systematic Use | Phase 4 | 2020-06-13 |
| Completed | Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Wrinkles Such as Nasolabial Folds | N/A | 2019-12-26 |
| Terminated | Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer Hot Flashes, Breast Cancer | Phase 2 | 2019-11-07 |
| Completed | Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate Pharmacokinetic of Tenofovir in Healthy Subjects | Phase 4 | 2019-04-22 |
| Completed | Pharmacokinetics of Two Formulation of Pregabalin Diabetic Peripheral Neuropathy, Fibromyalgia, Partial Seizure Disorder | Phase 4 | 2018-01-19 |
| Completed | Pharmacokinetics of Nalbuphine Injection Pain, Postoperative | Phase 4 | 2018-01-15 |
| Completed | Pharmacokinetics of Two Different Formulation of Voriconazole Fungus Infection | Phase 4 | 2016-06-01 |
| Completed | Pharmacokinetics of Two Formulations of Entecavir Hepatitis B | Phase 4 | 2015-12-01 |
| Completed | Bioequivalence of Two Formulations of Esomeprazole Healthy | Phase 4 | 2015-04-01 |
| Completed | Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy Nonsmall Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | — | 2014-11-01 |
| Completed | Bioequivalence of Two Formulations of Meropenem Intravenous Injection Healthy | Phase 4 | 2014-09-01 |
| Completed | A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labial Herpes Labialis | Phase 2 | 2014-07-01 |
| Completed | Bioequivalence of Two Formulations of Acyclovir Healthy | Phase 4 | 2014-04-01 |
| Completed | A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women PMS, Hot Flashes | Phase 2 | 2014-03-19 |
| Completed | A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Herpes Zoster | Phase 4 | 2011-04-01 |